← The SEC Ephemeris: the whole map
Teva Pharmaceuticals USA Fulvestrant
In the graph: all 4 documents (13 pages).
- Application
- NDA 210063
- Ticker
- Teva Pharmaceuticals USA
- Product
- Fulvestrant
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- October 26, 2017 · June 2, 2017 · September 30, 2016 · June 1, 2016
From FDA letters and SEC filings. Not investment or medical advice.